Zimmer Biomet Holdings Inc Total Assets
Zimmer Biomet Holdings Inc total assets. Based on the latest financial reports, Zimmer Biomet Holdings Inc (ZBH) holds total assets worth $23.49 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ZBH market cap for the company's overall valuation and market capitalisation.
Total Assets of Zimmer Biomet Holdings Inc (1999–2024)
Total assets of Zimmer Biomet Holdings Inc from 1999 to 2024. This chart illustrates how Zimmer Biomet Holdings Inc's total assets have evolved over time, based on quarterly financial data. See Zimmer Biomet Holdings Inc (ZBH) stock price for real-time trading data and today's change.
Zimmer Biomet Holdings Inc - Asset Composition Analysis
Zimmer Biomet Holdings Inc Total Assets Breakdown (December 2024)
Zimmer Biomet Holdings Inc total assets breakdown as of December 2024. Zimmer Biomet Holdings Inc's total assets of $23.49 Billion consist of 21.9% current assets and 78.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $525.50 Million | 2.5% |
| Accounts Receivable | $1.48 Billion | 6.9% |
| Inventory | $2.24 Billion | 10.5% |
| Property, Plant & Equipment | $2.26 Billion | 10.6% |
| Intangible Assets | $4.60 Billion | 21.5% |
| Goodwill | $8.95 Billion | 41.9% |
Asset Composition Trend (1999–2024)
This chart illustrates how Zimmer Biomet Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ZBH working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zimmer Biomet Holdings Inc's current assets represent 21.9% of total assets in 2024, a decrease from 71.0% in 1999.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2024, up from 0.0% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 0.0% in 1999.
- Asset Diversification: The largest asset category is goodwill at 41.9% of total assets.
Zimmer Biomet Holdings Inc Competitors by Total Assets
Key competitors of Zimmer Biomet Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Zimmer Biomet Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.43 | 1.36 | 1.99 |
| Quick Ratio | 1.39 | 0.70 | 1.03 |
| Cash Ratio | 0.00 | 0.16 | 0.00 |
| Working Capital | $3.43 Billion | $1.29 Billion | $2.53 Billion |
Zimmer Biomet Holdings Inc - Advanced Valuation Insights
This section examines the relationship between Zimmer Biomet Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.43 |
| Latest Market Cap to Assets Ratio | 0.87 |
| Asset Growth Rate (YoY) | -0.6% |
| Total Assets | $21.37 Billion |
| Market Capitalization | $18.53 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Zimmer Biomet Holdings Inc's assets close to their book value (0.87x), suggesting investors view the company's assets at approximately fair value.
Slight Asset Contraction: Zimmer Biomet Holdings Inc's assets decreased by 0.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Zimmer Biomet Holdings Inc (1999–2024)
The table below shows the annual total assets of Zimmer Biomet Holdings Inc from 1999 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $21.37 Billion | -0.61% |
| 2023-12-31 | $21.50 Billion | +2.05% |
| 2022-12-31 | $21.07 Billion | -10.19% |
| 2021-12-31 | $23.46 Billion | -3.94% |
| 2020-12-31 | $24.42 Billion | -0.90% |
| 2019-12-31 | $24.64 Billion | +2.12% |
| 2018-12-31 | $24.13 Billion | -7.25% |
| 2017-12-31 | $26.01 Billion | -2.51% |
| 2016-12-31 | $26.68 Billion | -2.64% |
| 2015-12-31 | $27.41 Billion | +184.48% |
| 2014-12-31 | $9.63 Billion | +0.56% |
| 2013-12-31 | $9.58 Billion | +6.30% |
| 2012-12-31 | $9.01 Billion | +5.84% |
| 2011-12-31 | $8.52 Billion | +6.44% |
| 2010-12-31 | $8.00 Billion | +2.75% |
| 2009-12-31 | $7.79 Billion | +7.55% |
| 2008-12-31 | $7.24 Billion | +9.12% |
| 2007-12-31 | $6.63 Billion | +11.04% |
| 2006-12-31 | $5.97 Billion | +4.41% |
| 2005-12-31 | $5.72 Billion | +0.46% |
| 2004-12-31 | $5.70 Billion | +10.46% |
| 2003-12-31 | $5.16 Billion | +500.30% |
| 2002-12-31 | $858.90 Million | +15.29% |
| 2001-12-31 | $745.00 Million | +24.71% |
| 2000-12-31 | $597.40 Million | -1.42% |
| 1999-12-31 | $606.00 Million | -- |
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skul… Read more